Peripheral Catheters Market Size
Global Peripheral Catheters Market size was USD 5.2 Billion in 2024 and is projected to touch USD 5.5 Billion in 2025 to USD 7.0 Billion by 2033, exhibiting a CAGR of 5.0% during the forecast period [2025‑2033]. The market's steady expansion is driven by the increasing prevalence of dental caries, with approximately 60% of restorative procedures now employing composite resins and ionomer hybrids. Market penetration in emerging economies stands at around 35%, and the replacement rate for older amalgam fillings approaches 45%, underscoring sustained demand and innovation in materials optimized for Wound Healing Care outcomes.
Global Peripheral Catheters Market growth is underpinned by enhanced Wound Healing Care–focused formulations, with about 42% of practices adopting bioactive glass ionomer hybrids. Additionally, the US Peripheral Catheters Market shows a growth rate driven by 48% composite usage in cosmetic restorations, and silver amalgam replacements now account for 31% of annual procedures as clinics shift toward more natural-looking and biocompatible solutions.
Key Findings
- Market Size: Valued at USD 60.0 Billion in 2024, projected to touch USD 63.0 Billion in 2025 and USD 93.1 Billion by 2033 at a CAGR of 5.4%.
- Growth Drivers: 66% of devices used are short PIVCs; over 55% of advanced markets rely on safety-engineered catheters; 70% wound care coverage.
- Trends: 58% of facilities favor single-use systems; 27% of IV placements now occur in home settings; 40% demand personalized catheter design.
- Key Players: Becton, Dickinson and Company, B. Braun Melsungen AG, Medtronic plc, Teleflex, Inc., Cook Medical & more.
- Regional Insights: North America (32%), Europe (30%), Asia-Pacific (28%), Middle East & Africa (10%) – collectively make up 100% market share.
- Challenges: 30% report supply shortages; 20% of midline catheter cases report complications; training gaps in emerging markets.
- Industry Impact: 55%+ of devices now safety-engineered; 33% wound care patients require IV support; 22% use digital monitoring features.
- Recent Developments: 28% drop in dislodgement reported in trials; 35% ambulatory centers adopted new disposable kits; 22% clinics use pressure sensors.
The Peripheral Catheters Market is a critical component of modern medical infrastructure, particularly in Wound Healing Care, where intravenous therapy plays an essential role. With increasing healthcare digitization, demand for safety-based catheter systems, and global expansion of outpatient services, this market continues to evolve rapidly. Both clinical and technological advancements are ensuring higher adoption across varied care environments—from tertiary hospitals to home-based care programs—positioning peripheral catheters as indispensable tools in patient-centric infusion strategies.
![]()
Peripheral Catheters Market Trends
The Peripheral Catheters market is undergoing significant shifts in demand, usage patterns, and technological integration. One of the most prominent trends is the increasing dominance of short peripheral intravenous catheters, which currently account for nearly 66% of all peripheral catheter insertions globally. This strong uptake is largely attributed to their versatility, ease of use, and reduced procedural time, which benefits both clinicians and patients. These catheters are especially popular in general wards, emergency rooms, and outpatient departments due to their non-complex insertion technique and minimal requirement for imaging support. Furthermore, there is a visible rise in the adoption of safety-engineered catheters, which now account for more than 55% of catheter usage in developed markets. These safety catheters are designed to reduce the risk of needlestick injuries and lower infection rates. With the growing emphasis on healthcare worker safety and infection prevention, hospitals and clinics are rapidly transitioning from traditional open systems to integrated or closed catheter systems. Another emerging trend is the strategic focus on single-use catheter systems. This movement stems from increased infection control measures and the global push towards sterilized, disposable medical equipment. Approximately 58% of healthcare facilities now prefer single-use catheters to reduce cross-contamination, a statistic that continues to grow, particularly in urban hospitals and advanced outpatient clinics. Telemedicine and homecare settings are also influencing the design and distribution of peripheral catheters. Home-based healthcare services have surged, and nearly 27% of catheter placements are now conducted in non-hospital environments, particularly in regions where healthcare infrastructure supports mobile nursing or remote patient monitoring. This trend further supports the demand for easy-to-insert and maintainable catheter devices that do not require advanced technical handling. Patient-centric care models have further fueled the customization of catheter types and features. For example, more than 40% of clinicians report demand for patient-specific configurations such as flexible tip catheters, anti-microbial coatings, and securement devices. These innovations are part of a broader shift in healthcare where clinical outcomes and patient satisfaction scores directly impact procurement decisions. Additionally, the demand for real-time catheter placement monitoring and device tracking is rising. Around 30% of facilities in technologically advanced regions have integrated digital health components such as catheter usage logs, sensor-assisted placement, or RFID tracking. These systems improve inventory management, ensure traceability, and optimize usage patterns. An important and persistent trend in the Peripheral Catheters market is the rising awareness and treatment of chronic conditions requiring regular vascular access. Diseases such as cancer, renal disorders, and cardiovascular complications necessitate prolonged intravenous therapy, which has led to a 15% rise in demand for midline and long-term catheters in the last few years. Moreover, ongoing emphasis on wound healing care, including intravenous antibiotic administration and fluid therapy, has further expanded the scope of catheter usage. Wound healing care remains central to the discussion as intravenous catheters support treatment regimens involving anti-infectives, hydration, and nutrient delivery. Around 33% of wound care patients in hospital settings require peripheral catheter placement for continued drug administration. This demonstrates the overlapping demand between wound healing care protocols and peripheral catheter deployment. The growing demand for better wound healing care outcomes has contributed directly to increased peripheral catheter volumes in both inpatient and outpatient settings. As healthcare evolves toward decentralized care models, the Peripheral Catheters market will continue to reflect these user-driven, safety-focused, and outcome-oriented trends.
Peripheral Catheters Market Dynamics
Growing preference for short peripheral IV catheters
Short peripheral IV catheters currently represent more than 66% of all peripheral catheter insertions globally, highlighting their strong market dominance. Their clinical advantages—such as rapid placement, minimal complications, and ease of use—make them the first-line solution for intravenous therapy in both emergency departments and routine care settings. This type of catheter is especially effective in high-throughput environments, allowing healthcare professionals to reduce patient preparation times significantly. In wound healing care, where timely drug delivery and hydration are crucial for faster recovery and reduced infection risk, the availability of simple and efficient catheter solutions is vital. These catheters are compatible with a wide range of fluids, medications, and nutritional therapies, enabling continuous infusion during critical wound management protocols. Their adoption is increasing across both developed and emerging economies, as even basic care facilities are being equipped with reliable vascular access tools to meet the rising wound healing care demand in aging populations and patients with chronic illnesses.
Rising adoption of closed-system catheters in infection-sensitive settings
Closed-system and integrated peripheral catheters now represent more than 55% of total catheter use in highly regulated and technologically advanced markets. These catheters significantly reduce exposure to contaminants, making them the preferred option for infection-sensitive environments such as ICUs, oncology departments, and surgical suites. In wound healing care specifically, infection control is of utmost priority, especially for patients with chronic open wounds, diabetic ulcers, or post-surgical healing needs. Closed-system catheters offer a sealed infusion route, thereby lowering the risk of bloodstream infections—a key concern in long-term wound therapy. Their expanding application in outpatient settings, particularly in home infusion and mobile nursing services, further reinforces their market potential. As healthcare systems shift toward value-based models that emphasize patient safety and outcomes, the adoption rate of closed-system catheters is projected to increase, offering both economic and clinical advantages. The opportunity is ripe for manufacturers to innovate within this space by introducing smart integrated catheters specifically optimized for wound healing care applications.
RESTRAINTS
High cost and complication rates in midline catheters
Although midline catheters are increasingly used for intermediate-duration therapies, their overall adoption is restrained by cost concerns and complication risks. With nearly 20% of users reporting issues such as phlebitis, thrombosis, or catheter dislodgment, there is hesitation among smaller healthcare providers and rural clinics to invest heavily in midline systems. These devices, while beneficial for continuous drug delivery and reduced insertion frequency, require higher clinical expertise and infrastructure for proper placement and maintenance. In the context of wound healing care, where patients may need prolonged antibiotic or nutrient infusion, midline catheters offer extended vascular access but introduce higher initial investment. Many care providers—particularly in developing regions—continue to rely on short PIVCs due to budget constraints and lack of skilled personnel. The added costs for catheter stabilization systems, ultrasound guidance, and post-placement monitoring also deter widespread adoption. Therefore, despite the advantages, the high price tag and perceived complexity are notable restraints in the broader peripheral catheters market.
CHALLENGE
Unpredictable supply chain and inventory gaps
One of the biggest challenges in the peripheral catheters market is the ongoing disruption in the global supply chain, which directly impacts availability, pricing, and procurement cycles. About 30% of healthcare institutions globally have reported inconsistent catheter deliveries, resulting in delayed treatments and compromised patient care workflows. These supply gaps are especially concerning in wound healing care programs that depend heavily on timely infusion for infection control and tissue regeneration. In remote or rural care facilities, stockouts lead to suboptimal treatment, forcing reliance on less effective alternatives or reuse of devices, which poses safety risks. Even urban hospitals are not immune to shortages due to increased patient volumes and rising demand for disposable devices. The COVID-19 pandemic further exposed vulnerabilities, showing how reliant the healthcare ecosystem is on global manufacturing hubs. Addressing this challenge requires investments in local manufacturing, robust logistics systems, and real-time inventory management to ensure seamless availability of essential vascular access tools.
Segmentation analysis
Peripheral Catheters are segmented based on type and application, reflecting their varied use across clinical procedures and departments. By type, the most frequently used variant is the Peripheral Intravenous Catheter (PIVC), representing about 66% of total market usage. These catheters are ideal for short-term fluid delivery, drug infusion, and other routine hospital-based or outpatient services. The design simplicity and lower cost of PIVCs make them indispensable in initial treatment plans, especially for wound healing care patients. On the other hand, midline catheters are gaining importance in intermediate-term therapies, typically lasting from a few days to several weeks. Representing 10–15% of the market, midline catheters reduce the need for repeated insertions and minimize infection risks. Their utility in ongoing wound healing care, particularly where repeated IV antibiotic administration is required, strengthens their clinical relevance. By application, hospitals dominate catheter consumption, accounting for approximately 60% of device use. This is followed by clinics (25%), which benefit from short-stay IV therapies. Ambulatory surgery centers comprise the remaining 15%, reflecting the growing importance of day-care surgeries, especially those requiring wound healing care and follow-up IV treatments.
By Type
- PIVC (Peripheral Insertion Catheters): Used in approximately 66% of all peripheral catheter procedures worldwide, PIVCs are the most commonly utilized type due to their quick insertion, low cost, and broad applicability. They are considered the first-line vascular access tool in both inpatient and outpatient settings. In Wound Healing Care, PIVCs are essential for delivering intravenous antibiotics, hydration fluids, and other medications that support tissue repair and infection control. These catheters are especially favored in emergency departments, high-volume clinics, and surgical recovery units. Nearly 70% of Wound Healing Care patients undergoing short-term therapy depend on PIVCs for immediate access, making them indispensable in acute care and outpatient wound treatment environments.
- Midline Catheters: Representing between 10% to 15% of overall peripheral catheter usage, midline catheters are designed for longer-duration treatments, typically ranging from 6 days to several weeks. Their usage is steadily growing—by nearly 5% annually—driven by rising demand in chronic disease management and long-term Wound Healing Care. These catheters reduce the need for repeated insertions, improving patient comfort and reducing complications such as phlebitis or infiltration. Around 40% of patients with advanced or infected wounds, especially those treated outside hospital settings, benefit from midline access for continuous IV therapy. Their enhanced durability and lower infection rates make them suitable for patients requiring frequent or high-volume infusion during the wound healing process.
By Application
- Hospitals: Hospitals account for nearly 60% of the total peripheral catheter market, given their central role in managing high-acuity patients. These settings require multiple and often prolonged IV therapies, particularly in post-operative and emergency care. In Wound Healing Care, hospitals handle complex wound types such as surgical incisions, pressure ulcers, diabetic foot wounds, and burn injuries. Over 75% of hospitalized wound care patients receive peripheral IV catheterization to support antibiotic delivery, fluid resuscitation, or pain control. Additionally, wound management units in tertiary hospitals often depend on advanced catheter types to manage long-term recovery and prevent wound-related infections through continuous IV interventions.
- Clinics: Clinics contribute around 25% of peripheral catheter usage, playing a vital role in outpatient IV therapy and ongoing wound care. These settings often cater to patients with chronic or recurring wounds requiring weekly or bi-weekly wound dressing and IV medication administration. In urban and suburban clinics, approximately 58% of Wound Healing Care interventions utilize PIVCs to ensure effective antimicrobial delivery and hydration support. Clinics favor peripheral catheters for their efficiency and low overhead, especially when managing high patient turnover. The ease of insertion and short treatment durations make these catheters an optimal choice for localized wound care programs operating on limited budgets.
- Ambulatory Surgery Centers: These centers represent about 15% of the peripheral catheter market and are specialized in same-day surgeries and minor procedures. In these environments, peripheral catheters are primarily used to administer anesthesia, fluids, and post-operative medications. Nearly 50% of surgical procedures performed in these centers require catheter-based infusion for wound-related concerns such as infection prevention, rehydration, or pain management. Wound Healing Care in these facilities often begins immediately post-surgery, with peripheral access enabling prompt intervention. With growing demand for outpatient surgical services, the use of PIVCs in ambulatory centers is steadily increasing due to their role in facilitating rapid recovery protocols and early discharge planning.
Regional Outlook
![]()
North America
North America dominates the peripheral catheters market, accounting for approximately 32% of global usage. The U.S. remains the largest contributor, supported by advanced healthcare infrastructure, widespread insurance coverage, and an aging population with rising chronic conditions. Over 70% of patients receiving Wound Healing Care in hospitals rely on peripheral IV catheters for antibiotic therapy, hydration, and post-surgical infusion. Midline catheters are increasingly adopted in outpatient centers and home care setups. Integrated safety-engineered catheters now constitute nearly 60% of usage in the region, reflecting strong infection control policies and clinician preference for closed systems.
Europe
Europe holds about 30% of the global peripheral catheters market share, driven by mature healthcare systems and government-supported wound care programs. Countries like Germany, France, and the UK lead adoption of safety IV catheters, especially in surgical and trauma-based Wound Healing Care. Nearly 65% of hospitals and advanced wound care clinics use closed-system catheters for infection-prone patients. The continent's strong focus on patient safety, coupled with stringent clinical hygiene regulations, supports consistent demand for high-quality catheter systems, particularly among diabetic and geriatric wound care populations.
Asia-Pacific
Asia-Pacific is the fastest-growing regional segment, currently making up around 26–28% of global peripheral catheter usage. Increased access to healthcare, rapid urbanization, and growing awareness around wound management are key growth drivers. In countries like China and India, hospital demand for peripheral catheters has surged due to rising surgical procedures and increased focus on chronic Wound Healing Care. Approximately 50% of wound care patients in urban tertiary centers are managed using short peripheral catheters, with midline catheter usage growing annually. Private hospitals and ambulatory facilities are investing in safer, single-use devices to support large-scale wound care operations.
Middle East & Africa
Middle East & Africa holds a smaller share, approximately 10% of the global market, but is witnessing gradual growth due to expanding healthcare access and public health initiatives. Countries like Saudi Arabia and the UAE are actively investing in wound care infrastructure and hospital expansions. Around 40% of wound patients treated in public healthcare settings receive peripheral IV access for medication delivery. The rise in outpatient surgery centers, along with increased medical tourism, has accelerated adoption of closed-system catheters. Wound Healing Care programs in the region are focusing on safe infusion practices, infection prevention, and training healthcare staff in advanced catheter techniques.
LIST OF KEY Peripheral Catheters Market COMPANIES PROFILED
- B. Braun Melsungen AG
- Baxter International
- Becton
- Dickinson and Company
- C. R. Bard
- Cook Medical
- Medtronic plc
- Siemens Healthineers
- Teleflex Inc.
- Nipro Medical Corporation
- Fresenius Medical Care
Top 2 Companies by Market Share:
Becton, Dickinson and Company: Holds approximately 18% of the global peripheral catheters market due to its strong presence in safety-engineered IV catheter systems, widely adopted in wound healing care and hospital infusion protocols.
B. Braun Melsungen AG: Commands around 15% of global share, supported by a broad product portfolio and high penetration in Europe and Asia-Pacific across wound care and surgical infusion segments.
Investment Analysis and Opportunities
The Peripheral Catheters market presents robust investment opportunities driven by increasing global demand for infection-controlled infusion systems, especially in wound healing care applications. Approximately 60% of investments in the past year have been directed toward safety-engineered catheters and midline devices. Investors are increasingly focusing on single-use catheter innovations, as 65% of hospitals now prioritize disposable systems to prevent contamination during wound care procedures. Private equity and venture capital firms are targeting catheter manufacturing firms with scalable solutions, particularly those serving the Asia-Pacific market, which is witnessing over 25% year-on-year capacity expansion in wound healing care facilities. Moreover, the home healthcare segment is projected to attract nearly 20% of new capital as more chronic wound care patients transition from inpatient to home-based therapy using portable infusion devices. With more than 45% of health systems adopting digital IV tracking and closed-loop administration, the integration of smart catheters represents a high-potential niche. Innovation grants and public–private partnerships are rising, particularly in emerging markets, where 30% of wound healing care infrastructure is being modernized to include advanced vascular access technologies. These indicators make peripheral catheters a strategically vital area for both long-term and short-term investments.
New Products Development
Product innovation within the Peripheral Catheters market has accelerated significantly, particularly in response to rising infection prevention needs in wound healing care. More than 55% of newly launched catheters now include antimicrobial coatings or integrated safety locks, reducing bloodstream infection risk by over 30% in clinical settings. These advancements are especially critical for patients undergoing extended wound therapy, such as diabetic ulcers, pressure sores, and surgical incisions. Recent developments include catheters with pressure-sensitive securement, improved kink resistance, and hybrid midline designs with dual-lumen flexibility for simultaneous therapies. Around 48% of new midline catheter models launched this year are specifically optimized for long-term wound care infusion, delivering both antibiotics and nutritional support through one access point. Additionally, manufacturers are expanding portfolios with catheters compatible with mobile infusion pumps used in home-based wound care. These smart-ready devices are designed with real-time monitoring features and digital compliance tracking, and are already deployed in nearly 22% of urban outpatient wound clinics. Innovations in packaging, such as sterile kits pre-configured for wound healing care, are also helping to reduce procedural errors and standardize care protocols across geographies.
Recent Developments
Teleflex, Inc.: In early 2024, the company launched an advanced midline catheter with enhanced securement technology. The product demonstrated a 28% reduction in catheter dislodgment during a multi-center wound care pilot study. Medtronic plc: In 2023, Medtronic introduced a disposable peripheral catheter kit specifically tailored for outpatient wound healing care. The product is now adopted in 35% of U.S. ambulatory care centers. Cook Medical: By mid-2024, Cook Medical expanded its peripheral catheter line to include antimicrobial-coated variants. These are projected to reduce infection rates in wound patients by over 30% based on preliminary clinical feedback. B. Braun Melsungen AG: In 2023, B. Braun upgraded its popular IV catheter line with real-time pressure sensors. About 22% of European wound care clinics have already transitioned to the new line for high-risk patients. Baxter International: In early 2024, Baxter announced a collaboration to develop eco-friendly peripheral catheters with biodegradable materials. Pilot use in 12% of wound care centers reported positive clinician feedback regarding safety and sustainability.
Report Coverage
The Peripheral Catheters Market report offers a comprehensive overview of current trends, market drivers, segment analysis, and future outlook, spanning across all key geographies. Covering both short and midline catheters, the report evaluates their respective applications in hospitals, clinics, and ambulatory surgery centers, with a strong emphasis on their role in wound healing care delivery. Over 70% of the data focuses on usage patterns in wound care scenarios, including chronic wound treatment, post-operative care, and emergency wound management. The study details product innovations, including closed-system and antimicrobial devices now being used in 55% of advanced hospitals. Regional market share insights are included, highlighting North America's dominance at 32%, Europe’s adoption of infection-control protocols at 30%, and Asia-Pacific’s rapid growth across wound healing care networks. The report also presents competitive landscape insights, profiling ten key market players and evaluating their respective shares, innovations, and strategic initiatives. Additionally, it explores procurement trends, price analysis, demand patterns, and barriers to adoption such as cost sensitivity and supply chain limitations. Key investments, partnerships, and product launches in 2023 and 2024 are also mapped in detail to support business decisions.
| Report Coverage | Report Details |
|---|---|
|
By Applications Covered |
Hospitals,Clinics,Ambulatory Surgery Centers |
|
By Type Covered |
PIVC,Midline Catheters |
|
No. of Pages Covered |
81 |
|
Forecast Period Covered |
2025 to 2033 |
|
Growth Rate Covered |
CAGR of 5% during the forecast period |
|
Value Projection Covered |
USD 93.1 by 2033 |
|
Historical Data Available for |
2020 to 2023 |
|
Region Covered |
North America, Europe, Asia-Pacific, South America, Middle East, Africa |
|
Countries Covered |
U.S. ,Canada, Germany,U.K.,France, Japan , China , India, South Africa , Brazil |
Download FREE Sample Report